02576.HK
Zhejiang Taimei Medical Technology Co., Ltd.
HKSE · Technology · Software - Application · CN
HKD 5.50
+8.59%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 532.0M | 499.3M | 551.2M | 573.1M | 549.2M |
| Cost of Revenue | 296.9M | 287.4M | 326.2M | 394.1M | 363.8M |
| Gross Profit | 235.1M | 211.9M | 224.9M | 179.0M | 185.4M |
| Operating Expenses | |||||
| R&D Expense | 80.9M | 76.6M | 87.1M | 169.2M | 233.7M |
| SG&A Expense | 229.7M | 196.8M | 382.0M | 384.9M | 49.0M |
| General & Admin Expense | 135.4M | — | 297.2M | 238.1M | 43.7M |
| Selling & Marketing Expense | 85.5M | — | 84.9M | 146.8M | 5.3M |
| Other Expenses | 23.7M | — | 8.3M | 21.5M | 345.5M |
| Total Operating Expenses | 334.3M | 273.4M | 477.4M | 575.6M | 628.2M |
| Cost and Expenses | 631.1M | 560.8M | 803.6M | 969.7M | 992.0M |
| Operating Income (EBIT) | (99.2M) | (61.5M) | (252.5M) | (396.6M) | (442.8M) |
| Non-Operating | |||||
| Interest Income | — | 34.7M | 35.8M | 41.7M | 22.9M |
| Interest Expense | — | 811.4K | 727.0K | 1.4M | 2.7M |
| Net Interest Income | 14.4M | 33.9M | 35.0M | 40.2M | 20.2M |
| Other Non-Op Income/Expense | 29.6M | 12.1M | 35.0M | 40.2M | 20.2M |
| Non-Operating Income (excl Interest) | (18.4M) | (12.9M) | (35.8M) | (41.7M) | (22.9M) |
| EBT (Pre-Tax Income) | (69.6M) | (49.4M) | (217.4M) | (356.4M) | (422.6M) |
| Income Tax Expense | — | — | — | 15.0K | — |
| Bottom Line | |||||
| Net Income | (65.2M) | (41.7M) | (214.6M) | (346.8M) | (412.9M) |
| Earnings from Cont. Ops | (69.6M) | (49.4M) | (217.4M) | (356.4M) | (422.6M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (65.2M) | (41.7M) | (214.6M) | (346.8M) | (412.9M) |
| Per Share | |||||
| Basic EPS | (HK$0.12) | (HK$0.07) | (HK$0.39) | (HK$0.62) | (HK$0.74) |
| Diluted EPS | (HK$0.12) | (HK$0.07) | (HK$0.39) | (HK$0.62) | (HK$0.74) |
| Revenue Per Share | HK$0.94 | HK$0.89 | HK$0.98 | HK$1.02 | HK$0.98 |
| Shares | |||||
| Basic Shares Outstanding | 563.8M | 563.8M | 563.8M | 560.4M | 560.4M |
| Diluted Shares Outstanding | 563.8M | 563.8M | 563.8M | 560.4M | 560.4M |
| Profitability Metrics | |||||
| EBITDA | (74.5M) | (29.1M) | (176.7M) | (303.0M) | (364.4M) |
| D&A | 6.2M | 19.5M | 39.9M | 52.0M | 55.5M |
| EBIT | (80.8M) | (48.6M) | (216.7M) | (354.9M) | (419.9M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026